Global pharma major Lupin Limited (Lupin) today announced its S&P Global ESG scores have moved up to 76 from 69 last year, well above the industry average of 30 in the pharmaceuticals sector.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback